Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Genmab Launches Novel Drug for R/R DLBCL Treatment
Genmab A/S introduces EPKINLY™ (epcoritamab-bysp), the first and only T-cell engaging bispecific antibody for adult patients with R/R DLBCL, including DLBCL arising from indolent lymphoma and high-grade B‑cell lymphoma after multiple lines of therapy....
Breakthrough Drug Found for GPP Flare Prevention in Adults
Boehringer Ingelheim has made a significant discovery with the identification of spesolimab, an investigational medication that shows promise in preventing flares in adults suffering from generalized pustular psoriasis (GPP)....
Thermo Fisher Scientific Discover Novel Biomarkers to Treat Preeclampsia
Thermo Fischer Scientific has made a significant discovery by identifying new biomarkers, namely B•R•A•H•M•S PlGF plus KRYPTOR and B•R•A•H•M•S sFlt-1 KRYPTOR. These immunoassays have achieved breakthrough designation and clearance, making them the first and only tests to be approved for assessing the risk and managing preeclampsia....
Pfizer Discovers Novel Nasal Spray for the Treatment of Migraine
Pfizer has developed ZAVZPRET™ (zavegepant), the first and only new CGRP receptor antagonist nasal spray for the acute management of adult migraines. The U.S Food and Drug Administration (FDA) has given this spray its approval. An oral and intranasal formulation of zavegepant, a third-generation, selective, and structurally...
First-of-its Kind mRNA Vaccine Discovered for Resected Melanoma
The investigational personalised mRNA cancer vaccine mRNA-4157/V940 in combination with pembrolizumab (Keytruda) has been given a breakthrough therapy classification by the U.S. Food and Drug Administration (FDA) for the adjuvant treatment of patients with high-risk melanoma after complete resection....
Alzheimer's Disease Sinaptica Neurostim Therapy Receives FDA Breakthrough Designation
The SinaptiStim™ - AD System (AD) was developed by Sinaptica Therapeutics to treat Alzheimer's patients who are losing cognitive and functional abilities. The system is a novel integration for treating dementia patients that combines neurostimulation and brain wave monitoring technologies...
Pfizer Discovers Breakthrough Drug for Relapsed or Refractory Multiple Myeloma
Pfizer has discovered a new drug, elranatamab for the treatment of people with Relapsed or Refractory Multiple Myeloma (RRMM). Elranatamab is a B-cell maturation antigen (BCMA)-CD3-targeted bispecific antibody (BsAb)....
Akero's EFX for NASH Therapy has been designated as a Breakthrough Therapy
The U.S. Food and Drug Administration (FDA) has given Efruxifermin (EFX) a breakthrough therapy designation. EFX is a ground-breaking medication for the treatment of nonalcoholic steatohepatitis (NASH), a serious form of NAFLD (non-alcoholic fatty liver disease)....
Clinical Trial for Type 1 Diabetes Drug to Begin at Creative Medical Technology Holdings
The Creative Medical Technology Holdings Investigational New Drug (IND) application has been approved by the U.S. Food and Drug Administration, allowing the company to move forward with starting a clinical trial for Type 1 Diabetes using AlloStem™....
Neurophth Therapeutics Discover a New Gene Therapy Drug
A novel gene therapy medication candidate called NR082 has been identified by Neurophth Therapeutics (rAAV2-ND4). The medicine has received a Breakthrough Therapy Designation (BTD) from China's National Medical Products Administration...
